These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3596636)

  • 1. Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.
    Kerr MA; Hussein YM; Potts RC; Beck JS; Sheriff MM
    Immunology; 1987 Jun; 61(2):117-23. PubMed ID: 3596636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The mechanism of action of the factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.
    Hussein YM; Kerr MA; Beck JS
    Immunology; 1987 Jun; 61(2):125-9. PubMed ID: 3496268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppress of the increase in free cytosolic calcium during the inhibition of T-cell activation by an autoantibody present in the serum of leprosy patients.
    Poulton TA; Gallagher A; Beck JS
    Immunology; 1989 Nov; 68(3):353-8. PubMed ID: 2592010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum lymphocytotoxic activity in leprosy.
    Rasheed FN; Locniskar M; McCloskey DJ; Hasan RS; Chiang TJ; Rose P; de Soldenhoff R; Festenstein H; McAdam KP
    Clin Exp Immunol; 1989 Jun; 76(3):391-7. PubMed ID: 2752595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of lepromatous leprosy (LL) serum factor(s) on normal blood lymphocytes.
    D'Souza D; Das BC; Thomas IM
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):666-73. PubMed ID: 2280117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depressive effect of serum from patients with leprosy on mixed lymphocyte reactions. Influence of anti-leprosy treatment.
    Nelson DS; Penrose JM; Waters MF; Pearson JM; Nelson M
    Clin Exp Immunol; 1975 Dec; 22(3):385-92. PubMed ID: 131666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific IgG autoantibodies are potent inhibitors of autoreactive T cell response to phytohemagglutinin-activated T cells.
    Wolf-Levin R; Azuma T; Aoki K; Yagami Y; Okada H
    J Immunol; 1993 Nov; 151(10):5864-77. PubMed ID: 8228265
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum inhibitory factor in lepromatous leprosy: its effect on the pre-S-phase cell-cycle kinetics of mitogen-stimulated normal human lymphocytes.
    Potts RC; Sherif MM; Robertson AJ; Gibbs JH; Brown RA; Beck JS
    Scand J Immunol; 1981 Sep; 14(3):269-80. PubMed ID: 7330599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dependence of proliferative activity of lymphocytes on basal levels of lymphocytic cyclic nucleotides in lepromatous leprosy patients.
    Balybin ES; Naumov VZ
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):52-6. PubMed ID: 3011927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation.
    Kawano M; Iwato K; Kuramoto A
    J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phorbol myristate acetate (PMA) and ionophore A23187 on interleukin-2 levels and proliferation of activated T lymphocytes from patients with lepromatous leprosy.
    Alfaro-Bustamante F; Ramirez-Flores G; Gonzalez-Mendoza A; Islas-Rodriguez A; Fafutis-Morris M
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):73-9. PubMed ID: 9207756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biologic and molecular characterization of the IgG serum blocking factor (SBF-IgG) isolated from sera of patients with EBV-induced infectious mononucleosis.
    Veltri RW; Kikta VA; Wainwright WH; Sprinkle PM
    J Immunol; 1981 Jul; 127(1):320-8. PubMed ID: 6263976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand.
    Center DM; Cruikshank WW; Berman JS; Beer DJ
    J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary immunoglobulins and antibody activities in leprosy.
    Abe M; Yoshino Y; Minagawa F; Miyaji I; Sampoonachot P; Ozawa T; Sakamoto Y; Saito T; Saikawa K
    Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):343-50. PubMed ID: 6541202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma factors in delayed-type hypersensitivity. Augmentation of lymphocyte responses in borderline leprosy reactions.
    Bjune G; Barnetson RS
    Clin Exp Immunol; 1976 Dec; 26(3):397-402. PubMed ID: 1087592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.
    Godal T; Myklestad B; Samuel DR; Myrvang B
    Clin Exp Immunol; 1971 Dec; 9(6):821-31. PubMed ID: 4945738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.